Payer

Novo Nordisk, which manufactures Ozempic and Wegovy, has hired a lobbying firm to convince Congress to allow Medicare to cover the drugs for weight loss, Politico reported June 16. 

Aetna is defending a Medicare Advantage plan for retired New York City employees in court, and parent company CVS Health is sparring with Cigna over an executive's noncompete agreement. 

Medicare spending will grow by 8 percent in 2023, driven by higher hospital utilization and enrollment, CMS projects.

Aetna is seeking to defend a contract to provide a Medicare Advantage plan for New York City's retired employees in court, and new research finds overpayments in the program could be larger than previously thought. 

The Supreme Court upheld the Justice Department's decision to dismiss a whistleblower lawsuit alleging a UnitedHealth Group subsidiary overcharged Medicare. 

New York City Mayor Eric Adams is overriding the city comptroller's attempt to block the implementation of its contract with Aetna to administer a Medicare Advantage plan for 250,000 city retirees. 

California's Department of Managed Healthcare has fined Kaiser Permanente $450,000 for sending mailings with enrollees' private health information to incorrect addresses.

Humana is anticipating its medical loss ratio will be at the top end of its full-year projected range of 86.3 percent to 87.3 percent, according to a June 16 SEC filing. 

The Alliance of Community Health Plans is proposing a set of policies aimed at curbing misleading marketing in Medicare Advantage. 

The nation's retail pharmacy giants are playing an important role in Medicaid redeterminations through payer-agnostic outreach and education initiatives aimed at customers and employees in all 50 states.